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The finding that a carbohydrate infusion at currently rec-
ommended rates (170 mg/kg/h) was unable to stimulate 
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albumin synthesis in postoperative patients emphasizes 
the resistance of albumin metabolism toward parenteral 
nutrition measures. In healthy patients, albumin synthe-
sis may be only stimulated by markedly elevated insulin 
concentrations (at least 3 to 4 times higher than the 
postabsorptive level), which, however, cannot be achieved 
by currently recommended carbohydrate infusion rates 
and may be still ineffective because of an altered insulin 
dose/response kinetics during conditions of postoperative 
stress.
Introduction
Insulin rapidly stimulates protein synthesis by acti-
vating components of the translational machinery, factors 
including eukaryotic initiation factors and elongation fac-
tors. In the long term, insulin also increases the cellular 
Background: Insulin regulates albumin synthesis in vitro and in 
various experimental models. The current study was undertaken 
to determine the effects of a physiologic hyperinsulinemia on 
albumin synthesis in postoperative patients in whom plasma 
albumin concentrations are decreased. Methods: Studies 
were performed in postabsorptive patients after major abdomi-
nal operations. Mass spectrometry techniques were used to 
directly determine the incorporation rate of 1-[13C]-leucine 
into albumin. Consecutive blood samples were taken during a 
continuous isotope (D-Glc) infusion (0.16 µmol/kg/min). 
Isotopic enrichments were determined at baseline (period I) and 
after a 4-hour D-glucose (D-Glc) infusion at currently recom-
mended rates (170 mg/kg/h, n = 10) or after infusion of saline 
(control group, n = 8) (period II). Results: After D-Glc infusion, 
plasma insulin concentrations increased significantly (period I, 
6.6 ± 1.8 µU/mL; period II, 21.4 ± 2.1 µU/mL; P < .01). In 
contrast, plasma insulin concentration remained constant in 
control patients (period I, 3.8 ± 0.9 µU/mL-1; period II, 5.9 ± 
1.1 µU/mL; not significant vs period I, but P < .005 vs the cor-
responding value at the end of period II in the control group). 
Hyperinsulinemia was without effect on fractional albumin syn-
thesis (period I, 12.8% ± 1.9%/d; period II, 11.9% ± 1.9%/d; not 
significant), and synthesis rates corresponded to those meas-
ured in controls (period I, 13.0% ± 1.2%/d; period II, 12.1% ± 
0.1%/d; not significant vs period I and vs D-Glc infusion). 
Conclusions: A standard D-Glc infusion is insufficient to 
increase albumin synthesis in postoperative patients. (JPEN J 
Parenter Enteral Nutr. 2011;35:405-411)
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content of ribosomes to augment the capacity for protein 
synthesis.1 Insulin regulates the expression of more than 
150 genes, indicating that this is a major action of this 
hormone.2 In primary cultures of rat hepatocytes, insulin 
was found to increase albumin gene expression, albumin 
messenger RNA (mRNA) content, and albumin synthesis 
in a dose-dependent manner.3,4 Correspondingly, experi-
mental insulin deficiency was associated with decreased 
albumin gene transcription, mRNA content, and synthe-
sis, and these decreases could be prevented by maintain-
ing animals on insulin therapy in these animals.5-7 
Comparable results could be obtained in diabetic humans 
in whom insulin withdrawal reduced albumin synthesis 
and insulin replacement normalized this rate again.8
In the present study, we examined the effect of mild 
hyperinsulinemia on albumin synthesis in postoperative 
patients in whom plasma albumin concentrations are 
decreased and in whom postabsorptive albumin synthetic 
rates (ASRs) are insufficient to rapidly correct the postop-
erative albumin deficit.9 To produce physiologic hyperin-
sulinemia, patients received an experimental parenteral 
infusion of D-Glc, which was given at currently recom-
mended rates. Studies were performed in patients who 
were recovering from major abdominal surgical proce-
dures. During the postoperative period, the systemic cata-
bolic response is known to peak. At this stage, these 
patients may serve as an ideal model to examine the effects 
of hepatic insulin during metabolic stress.
Methods
Patients
Two groups of postoperative patients (control n = 8; D-Glc 
infusion group, n = 10) with rectal carcinoma were care-
fully screened via medical history, physical examinations, 
and routine blood tests. All patients underwent a curative, 
low anterior resection. The groups were comparable (mean 
± SEM) with respect to age (control, 64.8 ± 3.9 years; 
D-Glc 64.0 ± 2.9 years), body mass index (control, 24.9 ± 
1.0 kg/ cm; 24.1 ± 0.6 kg/cm2), and postoperative tumor 
stage (Dukes B). No patient (before operation) and no 
control patient had a history of metabolic diseases or other 
clinically important comorbidity. Malnutrition before oper-
ation was excluded by a stable body weight during the 
preceding 2 months, albumin concentrations in the normal 
range, and subjective global assessment.
All patients had comparable perioperative management, 
including preoperative bowel preparation (orthograde flush-
ing by oral colonoscopy fluids) and prophylactic intrave-
nous antibiotics perioperatively. Anesthesia included 
epidural application of analgetic and anesthetic drugs 
continued until postoperative day (POD) 5. Duration of 
operation, amount of blood loss, fluid replacement, and 
extent of the procedure were comparable. All patients had 
an uneventful postoperative course and were free from 
signs of organ malfunction and local or systemic infection 
at the time of the study.
Patients were studied between PODs 8 and 10, when 
body protein loss and depression of muscle protein 
synthesis were found to be maximal.10,11 According to 
clinical and biochemical examinations, symptoms of sys-
temic inflammatory response syndrome (SIRS), including 
fever and leukocytos, but also perioperative volume shifts 
had abated at that time, and all patients were in a similar 
phase of postoperative recovery. Fluid balance was equili-
brated and combined with a normal hydration state. A 
portion of the data (ASRs and amino acid concentrations 
of the 8 control patients) were presented in a previous 
publication.12
Informed consent was obtained after the experimen-
tal protocol had been explained in detail. The study was 
approved by the local institutional review board.
Experimental Protocol
All patients were inpatients of the general surgical ser-
vice. Patients received approximately 15 kcal/kg/d on 
PODs 1–3 and then 25 kcal kg/d until the day of the 
study. If spontaneous oral intake was insufficient, missing 
amounts of calories or protein were given parenterally. 
During the days before the study, calorie and protein/
amino acid supplies were comparable between groups. 
After 10 pm, all patients were fasted, except for the con-
sumption of mineral water. A primed, constant infusion of 
1-13C-leucine (Tracer Technologies, Sommerville, MA, 
99.3 atom percent enrichment) was started at 7 am the 
next day and continued for 10 hours. The infusion rate 
was 0.16 µmol/kg min (prime 9.6 µmol/kg-1). A blood 
sample was collected before isotope infusion to determine 
the background enrichment of albumin-bound leucine 
and plasma ketoisocaproic acid (KIC). In all patients, the 
first arterialized blood sample was taken after 180 min-
utes of isotope infusion, the second after 360 minutes, 
and the third after 600 minutes. Period I ranged from 
minutes 180 to 360, and period II from minutes 360 to 
600. Arterialized samples were obtained from a heated 
dorsal hand vein. For heating, the patients placed their 
nondominant hand in a warm box containing air at 
60°C–70°C for a 20-minute period.13
Between minutes 360 and 600 (after the second sam-
ple, period II), patients in the D-Glc infusion group 
received a continuous D-Glc infusion (170 mg/kg/h). 
Patients in the control group remained in a fasting state 
(saline infusion). Arterialized blood samples for measure-
ment of glucose and insulin concentrations were taken at 
the same time as blood samples for measurement of albu-
min synthesis.
Procedures
The principles of the methods and the generation of 
the data have been presented and discussed in detail in 
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previous publications.9,14,15 Plasma KIC and albumin-
bound leucine in plasma samples were separated by pre-
cipitation of the proteins.
Albumin was isolated by a highly specific separation 
method (ethanol extraction with subsequent electro-
phoretic purification). For capillary gas chromatography 
(GC)/combustion isotope ratio mass spectrometry (IRMS) 
analysis, amino acids from albumin were then converted 
to the N-acetyl n-propyl (NAP) ester. For GC/quadrupole 
mass spectrometry (GC/MS) analysis, we prepared the 
quinoxalinol-trimethylsilyl (TMS) derivative from KIC. 
NAP-amino acid derivatives were analyzed in a capillary 
GC/combustion IRMS system that consisted of a Hewlett-
Packard 5890 Series II gas chromatograph (Böblingen, 
Germany) that was interfaced to a mass spectrometer 
Delta S (Finnigan MAT, Bremen, Germany). Quinoxalinol 
TMS derivatives were analyzed by a GC/MS system 
(MSD 5971D; Hewlett-Packard). Isotopomer ratios of 
the sample were obtained by electron impact ionization 
and selected ion monitoring at mass-to-charge ratios 
(m/e) 259 and 260. Data were expressed as tracer/tracee 
ratios z (leucine and KIC enrichment).
Albumin concentrations were measured on samples 
taken before leucine administration with the bromocresol 
green method. Plasma amino acid levels were measured 
by an autoanalyzer (Beckman Instruments, Fulton, CA) 
in all controls and in 5 patients receiving infusions of 
D-Glc.
Calculations
Albumin fractional synthetic rates (FSRs) in the meta-
bolic steady state were calculated by dividing the incre-
ment in albumin-bound 1-[13C]-leucine tracer/tracee 
ratio by the enrichment of the precursor pool enrich-
ment.16 As a substitute for the true precursor pool enrich-
ment (transfer RNA–bound amino acid enrichment), we 
used the plasma [13C]-KIC tracer/tracee ratio for albu-
min synthesis.17 Delta increments of albumin-bound 
1-[13C]-leucine enrichment between samples were calcu-
lated from isotope ratios [13C]/[12C] using a correction 
factor that takes into account dilution of the label at the 
carboxyl position by the other carbon atoms in the 
derivatized NAP-leucine.14 FSRs were then calculated as 
follows:
FSR=
z (t ) z (t )
{z (t ) z (t )}/2 t
*
1
*60*100*24 (%/d)L i+1 L i
p i p i+1
−
+ ∆
where zL(ti) and zL (ti+1) correspond to the tracer/tracee 
ratio of albumin-bound leucine in 2 subsequent samples 
(i and i+1), separated by the time interval Δt (minutes). zP 
(ti) and zP (ti+1) indicate the tracer/tracee ratios of plasma 
KIC in 2 subsequent samples. Average values between zP 
(ti) and zP (ti+1) were used as precursor enrichments for 
Table 1.  Tracer/Tracee Ratios of
1-13C-Ketoisocaproic Acid in Plasma
Group Sample 1 Sample 2 Sample 3
Control 5.10 ± 0.40 5.62 ± 0.38 5.85 ± 0.29a
D-Glc infusion 5.75 ± 0.54 6.14 ± 0.50 5.88 ± 0.56
Values are given as % (mean ± standard error of the mean). 
Sample 1 was taken after 180 minutes, sample 2 after 360 min-
utes, and sample 3 after 600 minutes of isotope infusion. 
Patients in the D-Glc infusion group received 170 mg/kg/h of 
glucose between sample 2 and 3. Control patients continued to 
fast throughout the study.
aP < .05 vs sample 1.
protein synthesis. The factors 60 (minutes), 100, and 24 
are needed to express the FSR in %/d.
Patients in the control group demonstrated a signifi-
cant increase in the plasma KIC enrichment during the 
10-hour isotope infusion (Table 1), possibly indicating a 
non–steady-state situation. However, Equation 1 can still 
be used, if piecewise constant functions between pairs of 
consecutive sampling points can be identified.16 Since the 
plasma KIC enrichment did not differ significantly between 
samples taken at 180 and 360 minutes and at 360 and 600 
minutes, respectively, one may assume a steady-state–like 
condition between sampling points 1 and 2 and between 
sampling points 2 and 3, justifying the use of Equation 1 
to calculate FSR separately for those 2 study intervals.
The absolute ASRs, that is, the total amount synthe-
sized per day (mg/kg/d), was measured by multiplying the 
FSR by the intravascular albumin mass and normalized for 
body weight. Intravascular albumin mass was assessed 
from the plasma albumin concentration and plasma vol-
ume, which was predicted from sex, age, and weight by 
using a nomogram.18
Statistics
Data are expressed as mean ± standard error of the mean. 
Albumin, glucose, and insulin concentrations and albu-
min protein synthetic rates from patients receiving paren-
teral D-Glc and from control patients were compared by 
the unpaired t test. The paired t test was used to compare 
albumin protein synthetic rates between periods I and II. 
A P value of ≤.05 was taken as indicating a significant 
difference.
Results
Plasma glucose and insulin concentrations rose signifi-
cantly during D-Glc infusion (glucose, end of period II: 
158.0 ± 3.8 mg/dL, P < .05 vs 102.2 ± 2.1 mg/dL at the 
end of period I; insulin, end of period II 21.4 ± 2.1 µU/
mL, P < .05 vs 6.6 ± 1.8 µU/mL at the end of period I) 
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whereas plasma glucose and insulin concentrations 
remained unchanged in control patients (glucose, end of 
period II: 96.3 ± 2.0 mg/dL, not significant vs 103.5 ± 3.8 
mg/dL at the end of period I; insulin, end of period II 5.9 
± 1.1 µU/mL, not significant vs 3.8 ± 0.9 µU/mL at the 
end of period I) resulting in a significant difference of 
serum insulin and plasma glucose concentrations between 
controls and patients receiving infusion of D-Glc at the 
end of period II (P < .05).
Total amino acid concentration remained unchanged 
in control patients (end of period II: 2,921 ± 86 µmol/L, 
not significant vs 2,871 ± 83 µmol/L at the end of period 
I) and in those patients in whom amino acid concentra-
tions were measured before and at the end of the carbo-
hydrate–glucose infusion (end of period II: 2,770 ± 181 
µmol/L, not significant vs 2,700 ± 216 µmol/L at the end 
of period I).
Baseline serum albumin concentrations were compa-
rable between control patients and patients receiving 
D-Glc (3.7 ± 0.2 g/dL, not significant vs 4.6 ± 0.4 g/dl in 
controls). Correspondingly, patients in both groups dem-
onstrated baseline albumin FSRs that were comparable 
(13.0% ± 1.2%/d and 12.8 ± 1.9%/d, not significant).
Analysis of tracer data showed that only in the D-Glc 
infusion group did the tracer/tracee ratio in the plasma 
KIC pool (= precursor pool for albumin synthesis) not 
change significantly over time (Table 1). In control 
patients, the precursor pool enrichment rose significantly 
over time. Thus, the enrichment in sample 3 (600 min-
utes of isotope infusion) was significantly higher than the 
corresponding enrichment in sample 1 (180 minutes of 
isotope infusion).
Figure 1 shows the values of albumin-bound leucine 
enrichment and the time curve of tracer incorporation 
into serum albumin in the D-Glc infusion and control 
patients studied. In both groups, tracer incorporation 
over time was comparable and linear. Corresponding to 
the linear tracer incorporation, also FSR of albumin 
remained stable during the 10-hour study. Thus, in 
patients in D-Glc infusion group, albumin synthesis was 
12.8% ± 1.9%/d in period I and 11.9% ± 1.9%/d in period 
II (not significant vs period I). Also in control patients, 
we observed comparable FSR of albumin in period I 
(13.0% ± 1.2%/d) and in period II (12.1% ± 0.1%/d, not 
significant vs period I). Similar results were obtained 
when absolute ASRs were calculated in both groups 
(Figure 2).
Discussion
This study shows that in patients who underwent a major 
abdominal surgical procedure, mild hyperinsulinemia/
hyperglycemia had no effect on albumin synthesis. Thus, 
after an increase of insulin concentrations from about 7 to 
21 µU/mL, FSRs and ASRs remained unchanged.
Insulin is commonly believed to be an important 
determinant of human albumin production, since in dia-
betic patients, insulin withdrawal and replacement 
directly correlate with albumin synthesis.8 In contrast, it 
Figure 1.  Time curves of tracer incorporation into serum albumin (tracer/trace ratio) in control patients and patients receiving 
D-Glc infusion. Patients in the D-Glc infusion group (solid squares) received 170 mg/kg/h of glucose between minutes 360 and 600 
of tracer infusion. Control patients (open squares) fasted throughout the study. Values are given as mean ± standard error of the 
mean.
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is controversial whether supranormal insulin concentra-
tions stimulate synthetic rates of splanchnic or global 
hepatic protein or of albumin. This controversy largely 
results from methodological restrictions in specific exper-
iments and from the ignorance of an in vivo dose response 
effect of insulin.
Experiments in which exogenous insulin was infused 
to test allover anabolic effects at the site of the liver are 
compromised by 2 confounding factors. First, high insu-
lin concentrations are known to inhibit peripheral amino 
acid release, with a subsequent reduction of visceral 
amino acid supply. Therefore, the associated hypoami-
noacidemia may explain why in dogs and humans, various 
degrees of hyperinsulinemia had no significant effect on 
splanchnic amino acid balances.19-21 Furthermore, when 
regional catheter techniques were combined with isotopic 
tracer infusion, studies in healthy humans revealed that 
profound hyperinsulinemia was associated even with a 
decrease in splanchnic protein synthesis.22
The second drawback relates to the study design. 
Many studies examined only global splanchnic protein 
synthesis during insulin infusion. However, interpretation 
of those global rates is difficult, since insulin might have 
differential and opposite effects on the synthesis of indi-
vidual proteins. In fact, estimates of splanchnic protein 
synthesis reflect the mean synthetic rate of a mixture of 
proteins with different turnover rates. Thus, it is possible 
that the stimulatory effect of insulin on the synthesis of 
some proteins could be obscured by the concomitant inhi-
bition of the synthesis of others with faster turnover rates 
and/or greater pool sizes. Such a hypothesis is supported by 
in vitro data indicating that insulin differentially regulates 
the production of specific mRNAs23-25 and by data obtained 
in humans demonstrating that short-term variations in 
insulin availability have opposite effects on the synthesis of 
several hepatic proteins such as albumin, fibrinogen, or 
antithrombin.8,26-28 Consequently, the fact that hyperin-
sulinemia did not increase splanchnic protein synthesis in 
healthy patients even when plasma amino acid concentra-
tions were simultaneously maintained29 would not exclude 
stimulatory effects on specific proteins such as albumin.
In our study, hepatic albumin synthesis did not 
change significantly during mild hyperinsulinemia. It can 
be excluded that the duration of D-Glc infusion (4 hours) 
was insufficient to allow detection of a stimulatory effect. In 
humans, albumin synthesis was found to rise as soon as 
30 minutes after an appropriate stimulatory trigger (ele-
vated hepatic amino acid exposure through the portal 
vein).30 It is also unlikely that an increased ASR that was 
already present before the D-Glc infusion prevented a 
subsequent rise. We have recently reported that postab-
sorptive albumin synthesis is accelerated in the postop-
erative state.9 However, even with such elevated basal 
rates, it could be shown that an additional parenteral 
substrate supply may further stimulate albumin produc-
tion, for example, during hemodialysis.31 Finally, it can be 
excluded that a simultaneous fall in arterial amino acid 
concentration counteracted a possible stimulatory effect 
of insulin on albumin synthesis. The degree of hyperin-
sulinemia in our study was low enough not to interfere 
with plasma amino acid concentrations. Also, the accom-
panying hyperglycemia can be excluded as a potential 
Figure 2.  Absolute rates of serum albumin synthesis in control patients and patients receiving D-Glc infusion. Period I ranged from 
minutes 180 to minutes 360 and period II from minutes 360 to minutes 600 of tracer infusion. Patients in the D-Glc infusion group 
(hatched bars) received 170 mg/kg/h of D-Glc between minutes 360 and 600 (period II). Control patients (open bars) fasted through-
out the study. Values are given as mean ± standard error of the mean.
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reason for the unaltered albumin synthesis. Hyperglycemia 
in combination with constant insulin concentrations does 
not interfere with human protein metabolism, leaving 
plasma leucine concentration or appearance rate unal-
tered,32,33 and variations in carbohydrate concentration 
are usually not regarded as effectors of changes in protein 
metabolism observed during hyperinsulinemic hyperglyc-
emia.34 Consequently, other reasons must exist to explain 
the absent effect of insulin on albumin synthesis. A thor-
ough analysis of the available literature reveals a possible 
insulin dose/response relationship that may, in addition, 
depend on the species under investigation.
It appears that the physiologic elevations of plasma 
insulin concentration observed during standard enteral or 
parenteral carbohydrate supply do not significantly alter 
albumin production in humans. Thus, a carbohydrate-
based oral diet was found to increase plasma insulin con-
centrations 2 to 3 times above basal values but was 
without effect on FSRs or ASRs compared with a fat-
based diet.35 A similar rise in plasma insulin concentra-
tion was reported by Ballmer et al,36 who administered 
parenteral carbohydrates at a rate of about 170 mg/kg/h 
in healthy humans. Using the flooding dose technique, 
these authors were also unable to identify a relevant 
change in albumin synthesis. Although the flooding dose 
technique may intrinsically interfere with the measure-
ment of albumin synthesis,37 the results by Ballmer et al36 
are well compatible with our negative results, which were 
obtained by a different tracer technique (continuous 
tracer infusion).
Only insulin concentrations that were 3 to 4 times 
higher than basal and that could be only produced by 
exogenous insulin infusion (0.4 mU/kg/min) increased 
albumin synthesis significantly. However, with those infu-
sion rates and insulin concentrations, arterial amino acid 
levels may already start to decline.26 Therefore, the insu-
lin effect on albumin synthesis is not linear. Pacy et al38 
infused almost twice as much insulin (0.7 mU/kg/min) 
but did not observe significant changes of albumin syn-
thesis. The most likely explanation for these negative 
results can be found in the associated decrease of plasma 
amino acid concentrations, which was more pronounced 
than with lower insulin infusion rates, thereby simultane-
ously blunting the stimulatory effect of insulin on albu-
min synthesis.38 However, with simultaneous amino acid 
replacement, albumin synthesis can be accelerated in 
humans, if sufficient insulin (1.0–2.0 mU/kh/min) or 
carbohydrates (250 mg/kg/h) are being infused.27,28,31 
Interestingly, the insulin effect appears to be species-
specific. Thus, insulin infusion rates between 0.7 and 0.8 
mU/kg/min did not increase ASRs in pigs, even in the 
presence of supranormal amino acid concentrations.17,39
It is also currently unknown whether the insulin dose/
response kinetics in healthy patients correspond to those 
found during catabolic stress. Thus, with respect to the 
stimulation of albumin synthesis, the half maximal insulin 
concentration might be significantly higher in surgical 
patients than in controls, and maximum insulin effects on 
albumin synthesis may depend on the underlying disease. 
It is therefore uncertain whether the stimulatory effects of 
large amounts of insulin together with sufficient amino 
acids27,28,31 could be reproduced in postoperative patients.
Nevertheless, the available evidence clearly points to a 
concentration-dependent effect of insulin on human albu-
min synthesis. At least in healthy patients, a stimulatory 
effect will only become evident when peripheral insulin 
concentrations rise at least 3-fold to 4-fold above the 
postabsorptive level and if euaminoacidemia is simultane-
ously maintained. However, such markedly elevated insulin 
concentrations cannot be achieved by currently recom-
mended carbohydrate infusion rates (200–250 g/d)40
but would require the additional infusion of exogenous 
insulin.
In conclusion, our results demonstrate that a stand-
ard D-Glc infusion is insufficient to increase albumin 
synthesis in postoperative patients.
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